A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total

Status Recruiting

Clinical Trial Summary

This study is being conducted at Healthcare Global Enterprises Ltd to evaluate the role of a novel Tracheo-Esophageal voice Prosthesis for total laryngectomy +/- partial pharyngectomy patients. 30 patients will be enrolled as an inpatient or outpatient.

Patients who are planned to undergo total laryngectomy +/- pharyngectomy surgery and trachea-esophageal puncture procedure.(for primary TEP insertion) or patients who have undergone total laryngectomy > 6weeks prior and are suitable candidates for secondary TEP insertion would be recruited to the study. Insertion of the TEP will be done in primary setting or secondary setting. Patients, who are undergoing primary TEP insertion, will be evaluated for speech/ voice at an interval of 6 weeks, 12 weeks and 6 months after the procedure. Patients who are undergoing secondary TEP insertion to be evaluated on the same day of the procedure along with evaluation at an interval of 6 weeks, 12 weeks and 6 months. All the patients will be evaluated clinically for a fluid leak (through and around the TEP) on the same days of voice analysis by giving test feeds under supervision.

Clinical Trial Description

This study is being conducted at Healthcare Global Enterprises Ltd to evaluate the role of a novel trachea-oesophageal prosthesis for total laryngectomy +/- partial pharyngectomy patients. 30 patients will be enrolled as an inpatient or outpatient.

Patients who are planned to undergo total laryngectomy +/- pharyngectomy surgery and trachea-esophageal puncture procedure.(for primary TEP insertion) or patients who have undergone total laryngectomy > 6weeks prior and are suitable candidates for secondary TEP insertion would be recruited to the study. Insertion of the TEP will be done in primary setting or secondary setting. Patients, who are undergoing primary TEP insertion, will be evaluated for speech/ voice at an interval of 6 weeks, 12 weeks and 6 months after the procedure. Patients who are undergoing secondary TEP insertion to be evaluated on the same day of the procedure along with evaluation at an interval of 6 weeks, 12 weeks and 6 months. All the patients will be evaluated clinically for fluid leak (through and around the TEP) on the same days of voice analysis by giving test feeds under supervision. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03039465
Study type	Interventional
Source	HealthCare Global Enterprise Ltd.
Contact	Vishal US Rao, MS
Phone	9739774949
Email	drvishalrao@yahoo.com
Status	Recruiting
Phase	N/A
Start date	April 18, 2016
Completion date	December 31, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01089803` - Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer	N/A
Completed	`NCT00026975` - Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients	Phase 2
Completed	`NCT01435252` - A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab	Phase 2
Recruiting	`NCT04174950` - Perioperative ERAS Based Nursing Intervention for Laryngeal Cancer Patients	N/A
Recruiting	`NCT05857202` - Oxidative Stress and Inflammation Biomarkers in Surgically Treated Patients With Laryngeal Cancer
Recruiting	`NCT06077643` - Workshops and Exchange Groups for Laryngectomized Patients
Not yet recruiting	`NCT06137378` - European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]	Phase 2
Active, not recruiting	`NCT02586207` - Pembrolizumab in Combination With CRT for LA-SCCHN	Phase 1
Recruiting	`NCT02012699` - Integrated Cancer Repository for Cancer Research
Recruiting	`NCT05375266` - Immune Biomarker Study for Head and Neck Cancer
Completed	`NCT03134976` - Wound Complications in Head and Neck Surgery
Recruiting	`NCT04650919` - Aortic Laryngeal Rehabilitation Graft	N/A
Recruiting	`NCT05830240` - A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer	Early Phase 1
Terminated	`NCT02437513` - NewBreez for Airway Protection in Head and Neck Cancer Patients With Chronic Aspiration	N/A
Completed	`NCT01633541` - Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer	Phase 2
Completed	`NCT01332682` - Resistance Training and Physical Functioning in Head and Neck Cancer Patients	Phase 1
Terminated	`NCT00011492` - Patient Evaluation for Head and Neck Surgery Branch Studies
Recruiting	`NCT05349487` - SpeakFree Heat and Moisture Exchanger (HME)	N/A
Completed	`NCT00467948` - Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients	Phase 3
Recruiting	`NCT06024980` - Using the Subglottic Pressure to Predict the Dysphagia After Partial Laryngectomy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total Laryngectomy Patients — TEP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms